Those ARBS with canonical AREs are proposed to have tumor suppressing activity in healthy prostate tissue while composite motifs containing both AR:FOXA1 motifs are enriched in primary PCa ARBS (41,76). The gene discussed is FOXA1; the disease is neoplasm.